Literature DB >> 24842916

Office, home, and ambulatory blood pressures as predictors of cardiovascular risk.

Teemu J Niiranen, Juhani Mäki, Pauli Puukka, Hannu Karanko, Antti M Jula.   

Abstract

Ambulatory blood pressure (BP) is considered as the gold standard of BP measurement although it has not been shown to be more strongly associated with cardiovascular risk than is home BP. Our objective was to compare the prognostic value of office, home, and ambulatory BP for cardiovascular risk in 502 participants examined in 1992 to 1996. The end point was a composite of cardiovascular mortality, myocardial infarction, stroke, heart failure hospitalization, and coronary intervention. We assessed the prognostic value of each BP in multivariable-adjusted Cox models. The likelihood χ2 ratio value was used to test whether the addition of a BP variable improved the model’s goodness of fit. After a follow-up of 16.1±3.9 years, 70 participants (13.9%) had experienced ≥1 cardiovascular event. Office (systolic/diastolic hazard ratio per 1/1 mm Hg increase in BP, 1.024/1.018; systolic/diastolic 95% confidence interval, 1.009–1.040/0.994–1.043), home (hazard ratio, 1.029/1.028; 95% confidence interval, 1.013–1.045/1.005–1.052), and 24-hour ambulatory BP (hazard ratio, 1.033/1.049; 95% confidence interval, 1.019–1.047/1.023–1.077) were predictive of cardiovascular events. When all 3 BP variables were included in the model simultaneously, only systolic/diastolic ambulatory BP was a significant predictor of cardiovascular events (P=0.002/<0.001). Home systolic/diastolic BP improved the fit of the model only marginally when added to a model including office BP (χ2=3.0/4.0, P=0.09/0.047). Ambulatory BP, however, improved the fit of model more clearly when added to office and home BP (χ2=9.0/12.3, P=0.001/<0.001). Our findings suggest that ambulatory BP is prognostically superior to office and home BP.

Entities:  

Mesh:

Year:  2014        PMID: 24842916     DOI: 10.1161/HYPERTENSIONAHA.114.03292

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  29 in total

Review 1.  Time to re-evaluate effects of renin-angiotensin system inhibitors on renal and cardiovascular outcomes in diabetic nephropathy.

Authors:  Hiromichi Suzuki; Tomohiro Kikuta; Tsutomu Inoue; Ukihiro Hamada
Journal:  World J Nephrol       Date:  2015-02-06

2.  Twenty-Four-Hour Ambulatory Blood Pressure versus Clinic Blood Pressure Measurements and Risk of Adverse Outcomes in Children with CKD.

Authors:  Elaine Ku; Charles E McCulloch; Bradley A Warady; Susan L Furth; Barbara A Grimes; Mark M Mitsnefes
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-13       Impact factor: 8.237

3.  The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study.

Authors:  Abayomi N Ogunwale; Alanna C Morrison; Wensheng Sun; Rhiannon C Dodge; Salim S Virani; Addison Taylor; Rebecca F Gottesman; Eric Yang; Peng Wei; John W McEvoy; Gerardo Heiss; Eric Boerwinkle; Christie M Ballantyne; Vijay Nambi
Journal:  Eur J Prev Cardiol       Date:  2016-02-11       Impact factor: 7.804

Review 4.  Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension?

Authors:  Yalcin Solak; Kazuomi Kario; Adrian Covic; Nathan Bertelsen; Baris Afsar; Abdullah Ozkok; Andrzej Wiecek; Mehmet Kanbay
Journal:  Clin Exp Nephrol       Date:  2015-10-22       Impact factor: 2.801

5.  Pulse Arrival Time Based Cuff-Less and 24-H Wearable Blood Pressure Monitoring and its Diagnostic Value in Hypertension.

Authors:  Yali Zheng; Carmen C Y Poon; Bryan P Yan; James Y W Lau
Journal:  J Med Syst       Date:  2016-07-22       Impact factor: 4.460

6.  Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.

Authors:  Danielle Tientcheu; Colby Ayers; Sandeep R Das; Darren K McGuire; James A de Lemos; Amit Khera; Norman Kaplan; Ronald Victor; Wanpen Vongpatanasin
Journal:  J Am Coll Cardiol       Date:  2015-11-17       Impact factor: 24.094

Review 7.  Blood pressure variability: its relevance for cardiovascular homeostasis and cardiovascular diseases.

Authors:  Gianfranco Parati; Camilla Torlasco; Martino Pengo; Grzegorz Bilo; Juan Eugenio Ochoa
Journal:  Hypertens Res       Date:  2020-03-13       Impact factor: 3.872

Review 8.  Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review.

Authors:  Daichi Shimbo; Marwah Abdalla; Louise Falzon; Raymond R Townsend; Paul Muntner
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

9.  Long-term effects of baroreflex activation therapy: 2-year follow-up data of the BAT Neo system.

Authors:  Manuel Wallbach; Ellen Born; Deborah Kämpfer; Stephan Lüders; Gerhard A Müller; Rolf Wachter; Michael J Koziolek
Journal:  Clin Res Cardiol       Date:  2019-08-06       Impact factor: 5.460

Review 10.  Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review.

Authors:  Daichi Shimbo; Marwah Abdalla; Louise Falzon; Raymond R Townsend; Paul Muntner
Journal:  J Am Soc Hypertens       Date:  2015-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.